Shares of Morgan Stanley MS slipped 0.80% to $125.75 Monday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index SPX falling 1.07% to 5,906.94 and Dow ...

Individualized cancer vaccines and antibody-drug conjugates will be among the dominant biotech innovations in cancer next ...

Jim Lacamp, Morgan Stanley Wealth Management senior vice president, joins CNBC's 'Money Movers' to discuss his outlook on the ...

Morgan Stanley analyst Terence Flynn notes that BioNTech (BNTX) announced last week that it had reached a settlement agreement with the ...

Morgan Stanley maintains a solid balance sheet, with assets reaching $1.26t and shareholder equity rising to $103.6b. Read ...

In recent years, there has been a noted increase in the rates of chronic disease, as well as a growth in the number of ...

Turkey has initiated an antidumping investigation into the imports of certain steel products from China and South Korea. The ...

Read here for the advantages and risks of Morgan Stanley's Series A preferred shares vs. CoCos, with insights on market ...

Morgan Stanley has teamed up with cross-border money transmitter Wise to settle foreign-exchange payments for the investment ...

Whales with a lot of money to spend have taken a noticeably bullish stance on Morgan Stanley. Looking at options history for Morgan Stanley MS we detected 18 trades. If we consider the specifics of ...

A portfolio of Brightview Senior Living communities spanning four markets, including Philadelphia, has sold to one of America ...

The stock's fall snapped a four-day winning streak.